应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GNMSF Genmab A/S
盘前交易 07-24 16:00:00 EDT 延时
资讯
新帖
简况
明晟公司MSCI北欧国家指数涨0.2%报355.29点北欧医疗保健板块领跑。生物技术公司Genmab A/S涨4.2%领
智通财经 · 07-08
明晟公司MSCI北欧国家指数涨0.2%报355.29点北欧医疗保健板块领跑。生物技术公司Genmab A/S涨4.2%领
【明晟公司MSCI北欧国家指数涨0.6%,报379.67点】明晟公司MSCI北欧国家指数涨0.6%,报379.67点。开发癌症抗体疗法的生物技术公司Genmab A/S涨8.5%,领跑一众成分股。最新业绩报告显示,该公司全年营收215.3亿丹麦克朗,分析师预期213.9亿克朗。
金融界 · 02-13
【明晟公司MSCI北欧国家指数涨0.6%,报379.67点】明晟公司MSCI北欧国家指数涨0.6%,报379.67点。开发癌症抗体疗法的生物技术公司Genmab A/S涨8.5%,领跑一众成分股。最新业绩报告显示,该公司全年营收215.3亿丹麦克朗,分析师预期213.9亿克朗。
加载更多
公司概况
公司名称:
Genmab A/S
所属市场:
PINK LIMITED
上市日期:
--
主营业务:
Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
发行价格:
--
{"stockData":{"symbol":"GNMSF","market":"US","secType":"STK","nameCN":"Genmab A/S","latestPrice":225,"timestamp":1753387200000,"preClose":225,"halted":0,"volume":0,"delay":15,"floatShares":62836515,"shares":63513622,"eps":18.35995,"marketStatus":"盘前交易","change":0,"latestTime":"07-24 16:00:00 EDT 延时","open":225,"high":225,"low":225,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":18.35995,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753450200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":225,"volumeRatio":1.3020772298463186},"requestUrl":"/m/hq/s/GNMSF","defaultTab":"news","newsList":[{"id":"2549292529","title":"明晟公司MSCI北欧国家指数涨0.2%报355.29点北欧医疗保健板块领跑。生物技术公司Genmab A/S涨4.2%领","url":"https://stock-news.laohu8.com/highlight/detail?id=2549292529","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549292529?lang=zh_cn&edition=full","pubTime":"2025-07-08 23:43","pubTimestamp":1751989403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LU0320765059.SGD","LU0289739343.SGD","LU0175139822.USD","LU1804176565.USD","LU2210149790.SGD","LU0289961442.SGD","BK4139","LU2210150020.SGD","LU1267930730.SGD","LU2265009873.SGD","LU0672654240.SGD","LU0511384066.AUD","MSCI","LU0708995401.HKD","LU0109391861.USD","GNMSF","LU2095319765.USD","BK4588","GMAB","LU0289960550.SGD","BK4112"],"gpt_icon":0},{"id":"2511655520","title":"【明晟公司MSCI北欧国家指数涨0.6%,报379.67点】明晟公司MSCI北欧国家指数涨0.6%,报379.67点。开发癌症抗体疗法的生物技术公司Genmab A/S涨8.5%,领跑一众成分股。最新业绩报告显示,该公司全年营收215.3亿丹麦克朗,分析师预期213.9亿克朗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511655520","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511655520?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:52","pubTimestamp":1739465543,"startTime":"0","endTime":"0","summary":"明晟公司MSCI北欧国家指数涨0.6%,报379.67点。开发癌症抗体疗法的生物技术公司Genmab A/S涨8.5%,领跑一众成分股。最新业绩报告显示,该公司全年营收215.3亿丹麦克朗,分析师预期213.9亿克朗。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14005248150518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GMAB","GNMSF","MSCI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genmab.com","stockEarnings":[{"period":"1week","weight":0.0129},{"period":"1month","weight":-0.0308},{"period":"3month","weight":0.061},{"period":"6month","weight":0.1328},{"period":"1year","weight":0.4021},{"period":"ytd","weight":0.2189}],"description":"Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.","exchange":"PINK LIMITED","name":"Genmab A/S","nameEN":"Genmab A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genmab A/S(GNMSF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Genmab A/S(GNMSF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Genmab A/S,GNMSF,Genmab A/S股票,Genmab A/S股票老虎,Genmab A/S股票老虎国际,Genmab A/S行情,Genmab A/S股票行情,Genmab A/S股价,Genmab A/S股市,Genmab A/S股票价格,Genmab A/S股票交易,Genmab A/S股票购买,Genmab A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genmab A/S(GNMSF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Genmab A/S(GNMSF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}